Trial Profile
Castration-resistant prostate cancer registry: An observational study in the Netherlands
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Abiraterone (Primary) ; Antineoplastics (Primary) ; Cabazitaxel (Primary) ; Docetaxel (Primary) ; Enzalutamide (Primary) ; Radium 223 chloride (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CAPRI
- 11 Mar 2019 Status changed from recruiting to completed.
- 01 Aug 2013 Additional lead trial centres identified as reported by Netherlands Trial Register.
- 01 Aug 2013 Status changed from planning to recruiting as reported by Netherlands Trial Register.